Product details
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, used primarily for the treatment of type 2 diabetes. It effectively improves blood sugar control and promotes weight loss by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying. offering a new therapeutic option for patients struggling with diabetes and obesity.
link:http://www.tirz-peptide.com
